Pinnacle Associates Ltd. Cuts Stock Holdings in Xylem Inc. $XYL

Pinnacle Associates Ltd. lowered its stake in shares of Xylem Inc. (NYSE:XYLFree Report) by 3.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 288,876 shares of the industrial products company’s stock after selling 10,153 shares during the quarter. Pinnacle Associates Ltd.’s holdings in Xylem were worth $39,339,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of XYL. AQR Capital Management LLC boosted its stake in shares of Xylem by 14.4% in the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after buying an additional 3,900 shares during the period. NewEdge Advisors LLC boosted its stake in shares of Xylem by 3.3% in the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock valued at $496,000 after buying an additional 132 shares during the period. Empowered Funds LLC boosted its stake in shares of Xylem by 56.1% in the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after buying an additional 3,120 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in shares of Xylem by 97.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock valued at $1,442,000 after buying an additional 5,509 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Xylem by 114.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock valued at $154,000 after buying an additional 635 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

Shares of Xylem stock opened at $109.09 on Thursday. Xylem Inc. has a 52 week low of $108.96 and a 52 week high of $154.27. The firm has a market capitalization of $25.93 billion, a P/E ratio of 27.14, a P/E/G ratio of 1.59 and a beta of 1.08. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. The firm’s 50 day moving average is $121.18 and its two-hundred day moving average is $133.10.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The firm had revenue of $2.13 billion during the quarter, compared to analysts’ expectations of $2.11 billion. During the same period in the previous year, the company earned $1.03 earnings per share. Xylem’s quarterly revenue was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Research analysts forecast that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem declared that its board has initiated a share buyback program on Wednesday, February 25th that authorizes the company to buyback $1.50 billion in outstanding shares. This buyback authorization authorizes the industrial products company to buy up to 4.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

Insiders Place Their Bets

In other news, Director Jerome A. Peribere purchased 1,210 shares of the company’s stock in a transaction that occurred on Monday, May 4th. The shares were purchased at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the purchase, the director directly owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This represents a 4.65% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.32% of the stock is owned by insiders.

Wall Street Analyst Weigh In

XYL has been the topic of a number of recent analyst reports. Robert W. Baird set a $161.00 price objective on shares of Xylem in a research report on Wednesday, February 11th. Stifel Nicolaus dropped their price objective on shares of Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Jefferies Financial Group reissued a “hold” rating and issued a $130.00 price objective (down from $140.00) on shares of Xylem in a research report on Tuesday, March 31st. UBS Group lifted their price target on Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Finally, William Blair assumed coverage on Xylem in a report on Monday, January 26th. They set an “outperform” rating for the company. Seven research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $152.77.

Check Out Our Latest Stock Analysis on Xylem

About Xylem

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

See Also

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.